BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37489265)

  • 1. Multifaceted Spindle Cell/Sclerosing Rhabdomyosarcoma With Role of Immunohistochemistry in Avoiding Misdiagnosis: A Multi-Institutional Study of 45 Distinct Tumors.
    Jain E; Munjal G; Sharma S; Brar Z; Bhardwaj N; Dewan A; Jain D; Jha S; Lobo A; Malik V; Arora S; Varshney J; Beg A; Sampat NY; Parwani AV; Balzer B; Varma M; Yadav BS; Sharma SK; Singh HP; Gogoi K; Kumar D; Bhandari V; Fulara LM; Kumar A; Singh H; Bhattacharya M; Dixit M; Mohanty SK
    Int J Surg Pathol; 2024 May; 32(3):496-506. PubMed ID: 37489265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
    Yang L; Zhang HJ; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
    Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
    Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle cell/sclerosing rhabdomyosarcoma: case series from a single institution emphasizing morphology, immunohistochemistry and follow-up.
    Zhao Z; Yin Y; Zhang J; Qi J; Zhang D; Ma Y; Wang Y; Li S; Zhou J
    Int J Clin Exp Pathol; 2015; 8(11):13814-20. PubMed ID: 26823695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
    Rekhi B; Dodd L; Dharavath B; Dutt A
    Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
    Bahrami A; Folpe AL
    Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
    Mentzel T
    Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
    Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
    Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
    [No Abstract]   [Full Text] [Related]  

  • 17. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
    Zhu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
    Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.